 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper128th MAINE LEGISLATURE
FIRST REGULAR SESSION-2017
Legislative Document No. 479
H.P. 342 House of  Representatives, February 9, 2017
An Act  To Inform Patients of  the Dangers of Addicting Opioids
Reference to the Committee on Health  and Human Services suggested and  ordered printed.
ROBERT  B. HUNT
Clerk
Presented by Representative SANDERSON  of Chelsea.
Cosponsored by Senator BRAKEY  of Androscoggin and
Representatives: FREDETTE of Newport, PARRY  of Arundel, TIMBERLAKE of Turner, 
WADSWORTH of Hiram.

 
 Page 1 - 128LR1032(01) -1 
 Be it enacted by the People of the State of Maine as follows:  1 
Sec. 1.  32 MRSA §2210, sub -§6 is enacted to read:  2 
6.  Opioid medication information disclosure.  Prior to prescribing an opioid 3 
medication to a patient, an individual licensed under this chapte r whose scope of practice 4 
includes prescribing opioid medication shall inform the patient of the risks of using the 5 
opioid medication, including but not limited to the risk of forming an addiction to the 6 
opioid medication, and receive from the patient a wr itten certification that the patient has 7 
been provided that information.  8 
Sec. 2.  32 MRSA §2600 -C, sub -§6 is enacted to read:  9 
6.  Opioid medication information disclosure.  Prior to prescribing an opioid 10 
medication to a patient, an individual licensed unde r this chapter whose scope of practice 11 
includes prescribing opioid medication shall inform the patient of the risks of using the 12 
opioid medication, including but not limited to the risk of forming an addiction to the 13 
opioid medication, and receive from the  patient a written certification that the patient has 14 
been provided that information.  15 
Sec. 3.  32 MRSA §3300 -F, sub -§6 is enacted to read:  16 
6.  Opioid medication information disclosure.  Prior to prescribing an opioid 17 
medication to a patient, an individual licensed under this chapter whose scope of practice 18 
includes prescribing opioid medication shall inform the patient of the risks of using the 19 
opioid medication, including but not limited to the risk of forming an addiction to the 20 
opioid medication, and rec eive from the patient a written certification that the patient has 21 
been provided that information.  22 
Sec. 4.  32 MRSA §3657, sub -§6 is enacted to read:  23 
6.  Opioid medication information disclosure.  Prior to prescribing an opioid 24 
medication to a patient, an individual licensed under this chapter whose scope of practice 25 
includes prescribing opioid medication shall inform the patient of the risks of using the 26 
opioid medication, including but not limited to the risk of forming an addiction to the 27 
opioid medicati on, and receive from the patient a written certification that the patient has 28 
been provided that information.  29 
Sec. 5.  32 MRSA §18308, sub -§6 is enacted to read:  30 
6.  Opioid medication information disclosure.  Prior to prescribing an opioid 31 
medication to a patient, an individual licensed under this chapter whose scope of practice 32 
includes prescribing opioid medication shall inform the patient of the risks of using the 33 
opioid medication, including but not limited to the risk of forming an addiction to the 34 
opioid medication, and receive from the patient a written certification that the patient has 35 
been provided that information.  36 
 
 Page 2 - 128LR1032(01) -1 
 SUMMARY  1 
This bill requires that a health care provider who is a prescriber of opioid medication 2 
must, before prescribing an opioid med ication, inform the patient of the risks of using the 3 
opioid medication, including but not limited to the risk of forming an addiction to the 4 
opioid medication, and receive from the patient a written certification that the patient has 5 
been provided that in formation.  6 
 
